Cargando…
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
Dementia is one of the leading causes of death and disability in older population. Previous reports have shown that antidementia medications are associated with longer survival; nonetheless, the prevalence of their use and the compliance with them are quite different worldwide. There is hardly any a...
Autores principales: | Balázs, Nóra, Bereczki, Dániel, Ajtay, András, Oberfrank, Ferenc, Kovács, Tibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811017/ https://www.ncbi.nlm.nih.gov/pubmed/34655009 http://dx.doi.org/10.1007/s11357-021-00470-7 |
Ejemplares similares
-
Dementia epidemiology in Hungary based on data from neurological and psychiatric specialty services
por: Balázs, Nóra, et al.
Publicado: (2021) -
Pregestational neurological disorders among women of childbearing age—Nationwide data from a 13-year period in Hungary
por: Bereczki, Dániel, et al.
Publicado: (2022) -
Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data
por: Iljicsov, Anna, et al.
Publicado: (2020) -
The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: A comparison to patients with cerebral infarction
por: Szatmári, Szabolcs, et al.
Publicado: (2020) -
Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
por: Pintér, Dávid, et al.
Publicado: (2021)